PD-1(hi)TIM-3(+) T cells associate with and predict leukemia relapse in AML patients post allogeneic stem cell transplantation.
about
Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia.Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia.Administration of a vasoactive intestinal peptide antagonist enhances the autologous anti-leukemia T cell response in murine models of acute leukemia.Functional exhaustion of CD4+ T cells induced by co-stimulatory signals from myeloid leukaemia cells.Programming the immune checkpoint to treat hematologic malignancies.Programmed cell death-1 pathway inhibition in myeloid malignancies: implications for myeloproliferative neoplasms.Immune Checkpoint Blockade and Hematopoietic Stem Cell Transplant.PD-1 blockade induces remissions in relapsed classical Hodgkin lymphoma following allogeneic hematopoietic stem cell transplantation.miR-28 modulates exhaustive differentiation of T cells through silencing programmed cell death-1 and regulating cytokine secretion.Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer.Higher PD-1 expression concurrent with exhausted CD8+ T cells in patients with de novo acute myeloid leukemia.Immune checkpoint molecules in acute myeloid leukaemia: managing the double-edged sword.Bone marrow CD8 T cells express high frequency of PD-1 and exhibit reduced anti-leukemia response in newly diagnosed AML patients.Targeting the Immune Microenvironment in Acute Myeloid Leukemia: A Focus on T Cell Immunity.
P2860
Q33734571-80180F1C-2798-489D-99B6-E0F36571FACAQ33814411-47FBD8CC-DF6C-4A4D-9EF6-3B6C5F1B0BD0Q38714704-D0B4221D-B7C3-4876-A081-C84483940625Q38733598-E92D1C87-63F8-4ECC-B2E5-E6406D00D96DQ38806070-33C44FC6-5A14-49F8-A857-5F5FA8124DF4Q39072004-C82135E0-79B5-4F6F-9ADA-047353036E6CQ39116985-9A430866-40A2-4D3F-B5A4-D6010FF9F3C8Q41897195-24861FD1-1211-425D-B31E-11513FF5C43DQ41992370-29738134-6411-41C8-8B00-A8E17B637D54Q47134013-66E20982-0BD0-43F4-9874-4AEC429969F1Q47151143-1879BC9C-71F4-457E-A06F-580C994BE2DDQ48273861-8DEA9869-9F96-43E6-B383-216B7C28C5A9Q52725128-969EDF5A-5C48-495B-9017-CBA02D665FACQ55299267-9901D75F-EFA7-44E1-853C-9988C5E04F8B
P2860
PD-1(hi)TIM-3(+) T cells associate with and predict leukemia relapse in AML patients post allogeneic stem cell transplantation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
PD-1(hi)TIM-3(+) T cells assoc ...... eic stem cell transplantation.
@ast
PD-1(hi)TIM-3(+) T cells assoc ...... eic stem cell transplantation.
@en
type
label
PD-1(hi)TIM-3(+) T cells assoc ...... eic stem cell transplantation.
@ast
PD-1(hi)TIM-3(+) T cells assoc ...... eic stem cell transplantation.
@en
prefLabel
PD-1(hi)TIM-3(+) T cells assoc ...... eic stem cell transplantation.
@ast
PD-1(hi)TIM-3(+) T cells assoc ...... eic stem cell transplantation.
@en
P2093
P2860
P356
P1433
P1476
PD-1(hi)TIM-3(+) T cells assoc ...... neic stem cell transplantation
@en
P2093
D F Claxton
W C Ehmann
P2860
P2888
P356
10.1038/BCJ.2015.58
P577
2015-07-31T00:00:00Z